Cargando…

Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study

BACKGROUND: We previously reported gut dysbiosis in patients with Parkinson’s disease (PD). OBJECTIVE: The aim of this study is to examine whether gut dysbiosis correlates with the progression of PD. METHODS: We examined changes in gut microbiota and demographic features in 2 years in 36 PD patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minato, Tomomi, Maeda, Tetsuya, Fujisawa, Yoshiro, Tsuji, Hirokazu, Nomoto, Koji, Ohno, Kinji, Hirayama, Masaaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665539/ https://www.ncbi.nlm.nih.gov/pubmed/29091972 http://dx.doi.org/10.1371/journal.pone.0187307

Ejemplares similares

Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson’s Disease
por: Hasegawa, Satoru, et al.
Publicado: (2015)

Inhalation of hydrogen gas elevates urinary 8-hydroxy-2′-deoxyguanine in Parkinson’s disease
por: Hirayama, Masaaki, et al.
Publicado: (2019)

Association between changes in visual evoked magnetic fields and non-motor features in Parkinson’s disease
por: Fujisawa, Yoshiro, et al.
Publicado: (2017)

Gut Dysbiosis in Patients with Anorexia Nervosa
por: Morita, Chihiro, et al.
Publicado: (2015)

Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
por: Yamashiro, Kazuo, et al.
Publicado: (2017)

Correction: Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
por: Yamashiro, Kazuo, et al.
Publicado: (2017)

Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
por: Hirayama, Masaaki, et al.
Publicado: (2023)

Gut microbiota in dementia with Lewy bodies
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson’s disease
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Expression of Concern: Progression of Parkinson’s disease is associated with gut dysbiosis: Two-year follow-up study
Publicado: (2023)

Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
por: Nishiwaki, Hiroshi, et al.
Publicado: (2020)

Counting the Countless: Bacterial Quantification by Targeting rRNA Molecules to Explore the Human Gut Microbiota in Health and Disease
por: Tsuji, Hirokazu, et al.
Publicado: (2018)

Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis
por: Manabe, Yusuke, et al.
Publicado: (2023)

Drinking hydrogen water and intermittent hydrogen gas exposure, but not lactulose or continuous hydrogen gas exposure, prevent 6-hydorxydopamine-induced Parkinson’s disease in rats
por: Ito, Mikako, et al.
Publicado: (2012)

Intestinal Collinsella may mitigate infection and exacerbation of COVID-19 by producing ursodeoxycholate
por: Hirayama, Masaaki, et al.
Publicado: (2021)

Effects of Pesticide Intake on Gut Microbiota and Metabolites in Healthy Adults
por: Ueyama, Jun, et al.
Publicado: (2022)

A latent allocation model for the analysis of microbial composition and disease
por: Abe, Ko, et al.
Publicado: (2018)

ENIGMA: an enterotype-like unigram mixture model for microbial association analysis
por: Abe, Ko, et al.
Publicado: (2019)

Hierarchical non-negative matrix factorization using clinical information for microbial communities
por: Abe, Ko, et al.
Publicado: (2021)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease
por: Jo, Sungyang, et al.
Publicado: (2022)

Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease
por: Suzuki, Anzu, et al.
Publicado: (2018)

Dysbiosis of skin microbiome and gut microbiome in melanoma progression
por: Mekadim, Chahrazed, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in the Development and Progression of Gastric Cancer
por: Miao, Yingying, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
por: Li, Peipei, et al.
Publicado: (2021)

Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
por: Roversi, Katiane, et al.
Publicado: (2021)

Gut Dysbiosis: A Target for Protective Interventions against Parkinson’s Disease
por: Lima, Illyane S., et al.
Publicado: (2023)

Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
por: Kinashi, Yusuke, et al.
Publicado: (2021)

Zooming into Gut Dysbiosis in Parkinson’s Disease: New Insights from Functional Mapping
por: Turco, Luigia, et al.
Publicado: (2023)

Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles -
por: Ichihara, Masatoshi, et al.
Publicado: (2015)

Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
por: Kaur, Gagandeep, et al.
Publicado: (2021)

Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
por: Teramoto, Yoshiki, et al.
Publicado: (2023)

Parkinson’s Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation
por: Dutta, Sudhir K, et al.
Publicado: (2019)

Dysbiosis in the Gut Microbiome in Streptozotocin-Induced Diabetes Rats and Follow-Up During Retinal Changes
por: Padakandla, Shalem Raj, et al.
Publicado: (2021)

Abnormal Blood Bacteriome, Gut Dysbiosis, and Progression to Severe Dengue Disease
por: Chancharoenthana, Wiwat, et al.
Publicado: (2022)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Gut Dysbiosis and Kidney Diseases
por: Cao, Chujin, et al.
Publicado: (2022)

Evaluation of gut dysbiosis using serum and fecal bile acid profiles
por: Monma, Tadakuni, et al.
Publicado: (2022)

COVID-19 and gut dysbiosis, understanding the role of probiotic supplements in reversing gut dysbiosis and immunity
por: Aldhafiri, Fahad K.
Publicado: (2022)

Roles of α-synuclein in gastrointestinal microbiome dysbiosis-related Parkinson's disease progression
por: Lei, Qingchun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m5q75s72ausci2qjr6bhs67dfe